Navigation Links
Optimer Reports Fourth Quarter and Fiscal Year 2011 Financial Results
Date:3/7/2012

ayment due to Par for the successful completion of the second DIFICID Phase 3 trial. Research and development expense for the fourth quarter of 2011 was $14.0 million, compared to $6.9 million for the fourth quarter of 2010. The increase was related to higher health economics and outcomes research as well as medical affairs expenses, DIFICID life cycle management planning, and preparation for a pediatric clinical trial.

For the fiscal year 2011, Optimer reported net income of $7.8 million, or $0.17 per share on both a basic and diluted basis, as compared to a net loss for the fiscal year of 2010 of $47.3 million, or ($1.25) per share on both a basic and diluted basis.  

Net income for the fourth quarter of 2011 was $13.4 million, or $0.29 and $0.28 per share on a basic and diluted basis, respectively, as compared to a net loss for the fourth quarter of 2010 of $11.9 million, or ($0.31) per share, on both a basic and diluted basis.  

As of December 31, 2011, Optimer held cash, cash equivalents and short-term investments of $110.6 million and had 46,689,951 shares outstanding.

2012 DIFICID Launch UpdateBetween January 1, 2012 and February 29, 2012, Optimer estimates approximately $11.0 million in DIFICID gross sales, representing 3,931 DIFICID treatments shipped to wholesalers.

Additionally, as of February 29, 2012:

  • Inventory levels at wholesalers remain within the range of 14 to 28 days of demand
  • Approximately 1,400 hospitals had ordered DIFICID
  • About 65% of hospitals covered by Optimer have reordered DIFICID
  • More than 600 hospitals are estimated to have placed DIFICID on formulary

  • Optimer 2011 and Recent Highlights

  • In December 2011, the EMA granted European marketing approval for DIFICLIR™ (fidaxomicin) tablets.
  • In October 2011, Optimer established a Canadian subs
    '/>"/>

  • SOURCE Optimer Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and FY 2011 Financial Results
    2. Optimer Pharmaceuticals to Present at the 32nd Annual Cowen Health Care Conference
    3. Optimer Pharmaceuticals Provides Update on DIFICID® (fidaxomicin) Tablets Launch
    4. Optimer Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
    5. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
    6. Optimer Pharmaceuticals to Present at BioCentury Newsmakers Conference
    7. Optimer Pharmaceuticals and Astellas Receive Positive Opinion from CHMP for European Approval of DIFICID™
    8. Optimer to Provide DIFICID™ Launch Update at Morgan Stanley Global Healthcare Conference
    9. Optimer Pharmaceuticals DIFICID Featured in 11 Presentations at 51st ICAAC
    10. Optimer Pharmaceuticals to Present at September 2011 Investor Conferences
    11. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/2/2015)... LONDON , Sept. 2, 2015 ... coil is used to treat an unruptured and ... artery wall). The treatment is either known as ... procedure, the endovascular coil blocks the blood flow ... usually performed under general anaesthesia by an interventional ...
    (Date:9/2/2015)... 2015 Advanced Wound Dressings - 5EU ... dressings have steadily replaced traditional bandages and gauze ... wound indications, such as trauma wounds, burns, and ... physical protection become increasingly critical in wound healing, ... therapy. This report focuses on nine market ...
    (Date:9/2/2015)... NEW YORK , Sept. 2, 2015   ... of the most common laboratory technologies that is used ... and antibodies in solution. ELISA test uses various types ... alkaline phosphatases and the result is detected by photometry ... in the treatment of various infectious diseases such as ...
    Breaking Medicine Technology:Global Neuroendovascular Coil Market 2015-2019 2Advanced Wound Dressings - 5EU Analysis and Market Forecasts 2Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019 2Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019 3
    ... May 3, 2011 Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) ... 2011. For the first quarter of 2011, Rigel reported ... to a net loss of $22.3 million, or $0.43 per share, ... the first quarter of 2011 and 2010 were 52.3 million and ...
    ... Therapeutics, Inc. (Nasdaq: NLTX ), a biopharmaceutical ... today announced dosing of the first patient in a ... cenderitide.  The trial is being conducted pursuant to Nile,s ... clinical step towards developing cenderitide as a treatment for ...
    Cached Medicine Technology:Rigel Announces First Quarter Financial Results 2Rigel Announces First Quarter Financial Results 3Rigel Announces First Quarter Financial Results 4Nile Therapeutics Announces Dosing of First Patient in Phase I Study of Cenderitide 2Nile Therapeutics Announces Dosing of First Patient in Phase I Study of Cenderitide 3
    (Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... their team will be participating at the highly anticipated Mississippi Gulf Babypalooza on ... mothers coming from all over, from Gulfport, Biloxi, and beyond. We will be ...
    (Date:9/3/2015)... ... September 03, 2015 , ... When looking at the types of people who have ... of two categories: those that have a weak appetite or those that have a fast ... to gain weight, CB-1 Weight Gainer gives three tips for slowing down metabolism. , The ...
    (Date:9/3/2015)... ... ... Earl Jones will be hosting an upcoming VOICES IN AMERICA segment that highlights the ... that discusses why it is important for the workplace to be healthier, the effects ... environment. , Employers are out billions of dollars year after year due to sick ...
    (Date:9/3/2015)... ... 2015 , ... The partnership will leverage Fidson’s strong and ... to promote LodonalTM in Nigeria. The distribution will become effective, upon completion of ... the product. , Managing Director, Fidson Healthcare Plc, Dr Fidelis Ayebae, expressed that ...
    (Date:9/2/2015)... ... September 03, 2015 , ... ... listed among the most influential leaders in healthcare, will offer the keynote address ... take place October 15-16, 2015, in Palm Harbor, Florida, at the Innisbrook Resort ...
    Breaking Medicine News(10 mins):Health News:State Farm Agent EJ Roberts to Help Expecting Mothers at the Mississippi Gulf Babypalooza 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 3Health News:James Earl Jones Hosts a New "Voices In America" Piece on Making the Workplace Healthier 2Health News:Fidson Partners US Firms on New Product Marketing 2Health News:Fidson Partners US Firms on New Product Marketing 3Health News:Fidson Partners US Firms on New Product Marketing 4Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 2Health News:ACO Coalition Meeting to Feature Leapfrog’s Leah Binder 3
    ... ... information on sexual health and sexual medicine easily accessible to the public and to ... TWSHF board of directors voted to dissolve the non-profit and donate its assets to ... ...
    ... , , , ... scientist M. Elizabeth "Betz" Halloran, M.D., M.P.H., D.S.c., has been awarded ... honor bestowed upon members of the American Association for the Advancement ... researcher in the Hutchinson Center,s Vaccine and Infectious Disease Institute and ...
    ... , LOS ANGELES, Dec. 17 ... and Energy-X lip balms, today announced the launch of ... heating/cooling treatment packs are specifically designed to reduce swelling ... variety of applications. Researchers behind Thermal-Aid created a line ...
    ... , Charmaine Yoest Urges "Comprehensive Respect for Life" in ... , WASHINGTON, Dec. 17 Americans United for Life Action President, ... Harry Reid as he considers a manager,s amendment - the Majority ... bill. The letter urges Senator Reid to include "specific language that ...
    ... from physician, study finds , THURSDAY, Dec. 17 (HealthDay News) ... parents to place infants on their backs to go to ... SIDS, researchers have found. , Since the U.S. government launched ... infants placed on their backs at sleep time has increased ...
    ... fall down on prevention, experts say , THURSDAY, Dec. ... getting better at treating heart attacks and other cardiovascular ... for preventing them, according to new statistics from the ... exercise, too much weight. , In fact, 59 percent ...
    Cached Medicine News:Health News:The Women's Sexual Health Foundation to Transfer Assets to the National Vulvodynia Association 2Health News:The Women's Sexual Health Foundation to Transfer Assets to the National Vulvodynia Association 3Health News:M. Elizabeth Halloran Named AAAS Fellow 2Health News:M. Elizabeth Halloran Named AAAS Fellow 3Health News:M. Elizabeth Halloran Named AAAS Fellow 4Health News:Thermal-Aid Bears Provide Warm Comfort to Children at Penny Lane for the Holidays 2Health News:Pro-Life Leader Sends Urgent Letter to Senator Reid 2Health News:Doctor's Orders Influence Baby's Sleep Position 2Health News:Obesity, Inactivity Keeping Heart Health Stats Down 2Health News:Obesity, Inactivity Keeping Heart Health Stats Down 3
    The Perfecta PDA components provide the design and material choice imperative in today's cost conscious medical climate....
    The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
    The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
    Severe revision options for the knee and hip...
    Medicine Products: